| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8227176 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
Bevacizumab does not appear to exacerbate the acute effects of IMRT. Late toxicities may have been worsened with this regimen. Further investigations of bevacizumab with LTAS and IMRT should be performed cautiously.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jacqueline M.D., Huong T. M.D., Sarah B.A., Erika B.A., Kasra M.D., Berit M.D., Alex M.D., Guobin M.D.,